Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

174 8 Interleukin-10 in Cancer Immunity
116 Lu ZY, Zhang XG, Rodriguez C, et al.
Interleukin-10 is a proliferation factor
but not a differentiation factor for human
myeloma cells. Blood 1995; 85:
2521±7.
117 Gu ZJ, Costes V, Lu ZY, et al. Interleukin-10
is a growth factor for human
myeloma cells by induction of an oncostatin
M autocrine loop. Blood 1996;
88: 3972±86.
118 Fluckiger AC, Durand I, Banchereau
J. Interleukin 10 induces apoptotic
cell death of B-chronic lymphocytic leukemia
cells. J Exp Med 1994; 179: 91±9.
119 Yue FY, Dummer R, Geertsen R, Hofbauer
G, Laine E, Manolio S, Burg G.
Interleukin-10 is a growth factor for human
melanoma cells and down-regulates
HLA class-I, HLA class-II and
ICAM-1 molecules. Int J Cancer 1997;
71: 630±7.
120 Matsuda M, Salazar F, Petersson M,
et al. Interleukin 10 pretreatment protects
target cells from tumor- and allospecific
cytotoxic T cells and downregulates
HLA class I expression. J Exp Med
1994; 180: 2371±6.
121 Salazar-Onfray F, Charo J, Petersson
M, et al. Down-regulation of the expression
and function of the transporter
associated with antigen processing
in murine tumor cell lines expressing
IL-10. J Immunol 1997; 159: 3195±202.
122 Salazar-Onfray F, Petersson M,
Franksson L, et al. IL-10 converts
mouse lymphoma cells to a CTL-resistant,
NK-sensitive phenotype with low
but peptide-inducible MHC class I expression.
J Immunol 1995; 154: 6291±8.
123 Hagenbaugh A, Sharma S, Dubinett
SM, et al. Altered immune responses in
interleukin 10 transgenic mice. J Exp
Med 1997; 185: 2101±10.
124 Sharma S, Stolina M, Lin Y, et al.T
cell-derived IL-10 promotes lung cancer
growth by suppressing both T cell and
APC function. J Immunol 1999; 163:
5020±8.
125 Bruserud O, Tore Gjertsen B, Terje
Brustugun O, et al. Effects of interleukin
10 on blast cells derived from patients
with acute myelogenous leukemia.
Leukemia 1995; 9: 1910±20.
126 Geissler K, Ohler L, Fodinger M,
et al. Interleukin 10 inhibits growth and
granulocyte/macrophage colony-stimulating
factor production in chronic myelomonocytic
leukemia cells. J Exp Med
1996; 184: 1377±84.
127 Kundu N, Dorsey R, Jackson MJ, et al.
Interleukin-10 gene transfer inhibits
murine mammary tumors and elevates
nitric oxide. Int J Cancer 1998; 76: 713±9.
128 Stearns ME, Rhim J,Wang M. Interleukin
10 (IL-10) inhibition of primary
human prostate cell-induced angiogenesis:
IL-10 stimulation of tissue inhibitor
of metalloproteinase-1 and inhibition
of matrix metalloproteinase
(MMP)-2/MMP-9 secretion. Clin Cancer
Res 1999; 5: 189±96.
129 Stearns ME, Garcia FU, Fudge K,
Rhim J,Wang M. Role of interleukin
10 and transforming growth factor b1
in the angiogenesis and metastasis of
human prostate primary tumor lines
from orthotopic implants in severe
combined immunodeficiency mice.
Clin Cancer Res 1999; 5: 711±20.
130 Huang S, Xie K, Bucana CD, Ullrich
SE, Bar-Eli M. Interleukin 10
suppresses tumor growth and metastasis
of human melanoma cells: potential
inhibition of angiogenesis. Clin Cancer
Res 1996; 2: 1969±79.
131 Huang S, Ullrich SE, Bar-Eli M.
Regulation of tumor growth and metastasis
by interleukin-10: the melanoma
experience. J Interferon Cytokine Res
1999; 19: 697±703.
132 Gerard CM, Bruyns C, Delvaux A,
et al. Loss of tumorigenicity and increased
immunogenicity induced by interleukin-10
gene transfer in B16 melanoma
cells. Hum Gene Ther 1996; 7:
23±31.
133 Kundu N, Fulton AM. Interleukin-10
inhibits tumor metastasis, downregulates
MHC class I, and enhances NK lysis.
Cell Immunol 1997; 180: 55±61.
134 Llorente L, Richaud-Patin Y, Garcia-Padilla
C, et al. Clinical and biologic
effects of anti-interleukin-10 monoclonal
antibody administration in systemic
lupus erythematosus. Arthritis
Rheum 2000; 43: 1790±800.